These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):264-70. PubMed ID: 17185301 [TBL] [Abstract][Full Text] [Related]
86. [Treatment of writer's cramp and other forms of limb dystonias with botulinum toxin]. Bogucki A Neurol Neurochir Pol; 1998; 32 Suppl 1():45-50. PubMed ID: 9608552 [TBL] [Abstract][Full Text] [Related]
87. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment. Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574 [TBL] [Abstract][Full Text] [Related]
92. Temporal processing of visuotactile and tactile stimuli in writer's cramp. Fiorio M; Tinazzi M; Bertolasi L; Aglioti SM Ann Neurol; 2003 May; 53(5):630-5. PubMed ID: 12730997 [TBL] [Abstract][Full Text] [Related]
93. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. Molho ES; Agarwal N; Regan K; Higgins DS; Factor SA Mov Disord; 2009 Jul; 24(9):1384-7. PubMed ID: 19441129 [TBL] [Abstract][Full Text] [Related]
95. Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience. Aquino CC; Felício AC; Castro PC; Oliveira RA; Silva SM; Borges V; Ferraz HB Arq Neuropsiquiatr; 2012 Sep; 70(9):662-6. PubMed ID: 22990720 [TBL] [Abstract][Full Text] [Related]
96. [Adduction spastic dysphonia: clinical and treatment]. García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438 [TBL] [Abstract][Full Text] [Related]
97. [A survey about the accessibility to botulinum toxin therapy for dystonia]. Mezaki T; Hayashi A; Nakase H; Hasegawa K No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446 [TBL] [Abstract][Full Text] [Related]
98. White matter abnormalities in dystonia normalize after botulinum toxin treatment. Blood AJ; Tuch DS; Makris N; Makhlouf ML; Sudarsky LR; Sharma N Neuroreport; 2006 Aug; 17(12):1251-5. PubMed ID: 16951564 [TBL] [Abstract][Full Text] [Related]
99. Impaired force control in writer's cramp showing a bilateral deficit in sensorimotor integration. Bleton JP; Teremetz M; Vidailhet M; Mesure S; Maier MA; Lindberg PG Mov Disord; 2014 Jan; 29(1):130-4. PubMed ID: 24123136 [TBL] [Abstract][Full Text] [Related]